Rosenstock, J., Diamant, M., Aroda, V. R., Silvestre, L., Souhami, E., Zhou, T., . . . Fonseca, V. (2016). Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial. Diabetes Care.

Rosenstock, Julio, Michaela Diamant, Vanita R. Aroda, Louise Silvestre, Elisabeth Souhami, Tianyue Zhou, Riccardo Perfetti, e Vivian Fonseca. "Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled On Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial." Diabetes Care 2016.

Rosenstock, Julio, et al. "Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled On Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial." Diabetes Care 2016.